Showing 1 posts of 1 posts found.
Novartis’ multiple myeloma treatment Farydak has been given an extended review by the FDA after its future seemed in jeopardy …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Novogenia breaks ground on personalised healthcare campus
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Care Quality Commission appoints Emily Miles as Chief Executive
National survey aims to improve glaucoma care across the UK